Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1Clear-cell metastatic renal cell carcinoma 1

Interventions

pembrolizumab 1lenvatinib 1cabozantinib 1Specimen Handling 1Pluvicto 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hyaluronoglucosaminidase 1CTLA-4 Antigen 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Clear-cell metastatic renal cell carcinoma × Pluvicto × Clear all
NCT06783348 2026-06-04

RENALUT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting
48 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡